Enoxaparin is not an oral factor Xa inhibitor. Response to Sutton et al. real-world clinical outcomes among US veterans with oral factor Xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate

被引：0
|
作者：
Buka, Richard J. [1 ]
Sutton, David J. [2 ]
Nicolson, Phillip L. R. [1 ,3 ]
机构：
[1] Univ Birmingham, Inst Cardiovasc Sci, Birmingham, England
[2] Univ Hosp North Midlands NHS Trust, Staffordshire Thrombosis & Anticoagulat Serv, Stoke on trent, England
[3] Univ Hosp Birmingham NHS Fdn Trust, Dept Clin Haematol, Birmingham, England
来源：
JOURNAL OF THROMBOSIS AND THROMBOLYSIS | 2024年 / 57卷 / 04期
关键词：
TRIALS;
D O I：
10.1007/s11239-024-02948-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：739 / 741
页数：3
相关论文
共 31 条
  • [1] Enoxaparin is not an oral factor Xa inhibitor. Response to Sutton et al. real-world clinical outcomes among US veterans with oral factor Xa inhibitor–related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate
    Richard J Buka
    David J Sutton
    Phillip LR Nicolson
    Journal of Thrombosis and Thrombolysis, 2024, 57 : 739 - 741
  • [2] Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate
    Sutton, S. Scott
    Magagnoli, Joseph
    Cummings, Tammy H.
    Dettling, Theresa
    Lovelace, Belinda
    Christoph, Mary J.
    Hardin, James W.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 56 (01) : 137 - 146
  • [3] REAL-WORLD CLINICAL OUTCOMES AMONG US VETERANS WITH ORAL FACTOR XA INHIBITOR-RELATED MAJOR BLEEDING TREATED WITH ANDEXANET ALFA OR 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE
    Sutton, S. Scott
    Magagnoli, Joe
    Cummings, Tammy H.
    Dettling, Terry
    Hardin, James
    Lovelace, Belinda
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : E107 - E108
  • [4] Correction to: Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate
    S. Scott Sutton
    Joseph Magagnoli
    Tammy H. Cummings
    Theresa Dettling
    Belinda Lovelace
    Mary J. Christoph
    James W. Hardin
    Journal of Thrombosis and Thrombolysis, 2023, 56 : 360 - 360
  • [5] Real-world clinical outcomes among US Veterans with oral factor xa inhibitor–related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate
    S. Scott Sutton
    Joseph Magagnoli
    Tammy H. Cummings
    Theresa Dettling
    Belinda Lovelace
    Mary J. Christoph
    James W. Hardin
    Journal of Thrombosis and Thrombolysis, 2023, 56 : 137 - 146
  • [6] Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate (Vol 56, pg 137, 2023)
    Sutton, S. Scott
    Magagnoli, Joseph
    Cummings, Tammy H. H.
    Dettling, Theresa
    Lovelace, Belinda
    Christoph, Mary J. J.
    Hardin, James W. W.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 56 (02) : 360 - 360
  • [7] REAL-WORLD MANAGEMENT OF ORAL FACTOR XA INHIBITOR BLEEDING-RELATED HOSPITALIZATIONS WITH ANDEXANET ALFA OR 4 FACTOR PROTHROMBIN COMPLEX CONCENTRATE
    Coleman, Craig I.
    Danese, Sherry
    Ulloa, Julie
    Xiao, Grace
    Lovelace, Belinda
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 2209 - 2209
  • [8] Lower mortality with andexanet alfa vs 4-factor prothrombin complex concentrate for factor Xa inhibitor-related major bleeding in a US hospital-based observational study
    Dobesh, Paul P.
    Fermann, Gregory J.
    Christoph, Mary J.
    Koch, Bruce
    Lesen, Eva
    Chen, Hungta
    Lovelace, Belinda
    Dettling, Theresa
    Danese, Mark
    Ulloa, Julie
    Danese, Sherry
    Coleman, Craig I.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (06)
  • [9] A meta-analysis of andexanet alfa and prothrombin complex concentrate in the treatment of factor Xa inhibitor-related major bleeding
    Jaspers, Tessa
    Shudofsky, Kimberly
    Huisman, Menno V.
    Meijer, Karina
    Khorsand, Nakisa
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2021, 5 (04)
  • [10] Retrospective Comparison of Andexanet Alfa and 4-Factor Prothrombin Complex for Reversal of Factor Xa-Inhibitor Related Bleeding
    Stevens, Victoria M.
    Trujillo, Toby C.
    Kiser, Tyree H.
    MacLaren, Robert
    Reynolds, Paul M.
    Mueller, Scott W.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2021, 27
1234